TECH

Bio Techne Stock Price

266.52
3.10 (1.18%)
Upgrade to Real-Time
Regular Market
266.52
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Bio Techne Corporation TECH NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
3.10 1.18% 266.52 261.995 267.84 263.15 263.42 14:12:05
Bid Price Ask Price Spread Spread % News
265.94 266.22 0.28 0.11% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,786 46,936 $ 265.84 $ 12,477,586 170,617 155.17 - 287.98
Last Trade Time Type Quantity Stock Price Currency
14:11:47 11 $ 266.26 USD

Bio Techne Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.19B 38.22M 33.87M $ 738.69M $ 229.29M 5.79 46.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 1.28 0.48% 8.61k 3.80%

more financials information »

Bio Techne News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TECH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week270.47271.23257.2503262.93122,733-3.95-1.46%
1 Month274.29286.68257.2503273.21152,240-7.77-2.83%
3 Months270.52286.68241.10263.24199,651-4.00-1.48%
6 Months204.80287.98155.17230.41239,41461.7230.14%
1 Year189.24287.98155.17220.99190,99477.2840.84%
3 Years118.56287.98116.11184.40183,779147.96124.8%
5 Years106.06287.9879.95151.74181,432160.46151.29%

Bio Techne Description

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells a variety of antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers, and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.


Your Recent History
NASDAQ
TECH
Bio Techne
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.